China Metastatic Liver Cancer Clinical Registry Cohort Database
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
- 试验地点
- 3
研究概览
简要总结
This study is led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close collaboration with multiple participating centers nationwide. The primary objective is to establish a standardized, large-scale clinical cohort database specifically for metastatic liver cancer. By collecting comprehensive data on patient demographics, primary tumor characteristics, systemic therapies, and local interventions, this registry aims to elucidate the clinical patterns and prognostic factors of secondary liver malignancies. This database will serve as a robust platform for conducting high-quality real-world studies and advancing evidence-based clinical research in the management of metastatic liver cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with histologically or radiologically confirmed metastatic liver cancer.
- •Age ≥ 18 years.
- •Patients who have voluntarily signed the informed consent form.
- •Patients with complete baseline clinical data.
排除标准
- •Patients with primary liver cancer (e.g., hepatocellular carcinoma).
- •Patients with other malignant tumors that may interfere with the evaluation of liver metastasis.
- •Patients who have previously participated in other interventional clinical trials.
- •Patients with severe cognitive disorders or communication barriers that prevent informed consent.
- •Patients with incomplete or missing key clinical data.